More articles from Volume 48, Issue 1, 2019
Clinical-morphological characteristics of pathological changes in the prostate
Serum Vitamin D analysis in acute viral bronchiolitis
Extracranial carotid atherosclerosis in genesis infarction brain in the border zones supratentorial localization
Oxidative stress parameters in patients with Meniere disease
The impact of occupational stress on work ability of electricians
Oxidative stress parameters in patients with Meniere disease
,
Aleksandar Stojanov
J. Stojanov
Abstract
References
1.
Sajjadi H, Paparella MM. Meniere’s disease. Vol. 372, The Lancet. 2008. p. 406–14.
2.
Pierce NE, Antonelli PJ. Endolymphatic hydrops perspectives 2012. Vol. 20, Current Opinion in Otolaryngology & Head and Neck Surgery. 2012. p. 416–9.
3.
Paparella MM. The Cause (Multifactorial Inheritance) and Pathogenesis (Endolymphatic Malabsorption) of Meniere’s Disease and Its Symptoms (Mechanical and Chemical). Vol. 99, Acta Oto-Laryngologica. 1985. p. 445–51.
4.
Matsuoka H, Kwon SS, Barbieri M, Yazawa Y, Yoo TJ. Induction of Endolymphatic Hydrops by Directly Infused Monoclonal Antibody against Type Ii Collagen CB11 Peptide. Vol. 111, Annals of Otology, Rhinology & Laryngology. 2002. p. 587–92.
5.
Hietikko E, Sorri M, Männikkö M, Kotimäki J. Higher Prevalence of Autoimmune Diseases and Longer Spells of Vertigo in Patients Affected With Familial Ménière’s Disease: A Clinical Comparison of Familial and Sporadic Ménière’s Disease. Vol. 23, American Journal of Audiology. 2014. p. 232–7.
6.
Gazquez I, Soto-Varela A, Aran I, Santos S, Batuecas A, Trinidad G, et al. High Prevalence of Systemic Autoimmune Diseases in Patients with Menière’s Disease. Vol. 6, PLoS ONE. p. e26759.
7.
Yoo TJ, Ge X, Sener O, Mora M, Kwon SS, Mora F, et al. Presence of Autoantibodies in the Sera of Meniere’s Disease. Vol. 110, Annals of Otology, Rhinology & Laryngology. 2001. p. 425–9.
8.
Brambilla D, Mancuso C, Scuderi MR, Bosco P, Cantarella G, Lempereur L, et al. The role of antioxidant supplement in immune system, neoplastic, and neurodegenerative disorders: a point of view for an assessment of the risk/benefit profile. Vol. 7, Nutrition Journal. 2008.
9.
Halliwell B, Whiteman M. Measuring reactive species and oxidative damagein vivoand in cell culture: how should you do it and what do the results mean? Vol. 142, British Journal of Pharmacology. 2004. p. 231–55.
10.
Jangi S, Otterbein L, Robson S. The molecular basis for the immunomodulatory activities of unconjugated bilirubin. Vol. 45, The International Journal of Biochemistry & Cell Biology. 2013. p. 2843–51.
11.
Peng F, Deng X, Yu Y, Chen X, Shen L, Zhong X, et al. Serum bilirubin concentrations and multiple sclerosis. Vol. 18, Journal of Clinical Neuroscience. 2011. p. 1355–9.
12.
Roche M, Rondeau P, Singh NR, Tarnus E, Bourdon E. The antioxidant properties of serum albumin. Vol. 582, FEBS Letters. 2008. p. 1783–7.
13.
Tetik S, Kilic A, Aksoy H, Rizaner N, Ahmad S, Yardimci T. Oxidative stress causes plasma protein modification. Vol. 53. 2015. p. 25–30.
14.
Jansen EHJM, Beekhof PK, Cremers JWJM, Viezeliene D, Muzakova V, Skalicky J. Long-term stability of parameters of antioxidant status in human serum. Vol. 47, Free Radical Research. 2013. p. 535–40.
15.
Fabbrini E, Serafini M, Colic Baric I, Hazen SL, Klein S. Effect of Plasma Uric Acid on Antioxidant Capacity, Oxidative Stress, and Insulin Sensitivity in Obese Subjects. Vol. 63, Diabetes. 2014. p. 976–81.
16.
Kondo M, Kiyomizu K, Goto F, Kitahara T, Imai T, Hashimoto M, et al. Analysis of vestibular-balance symptoms according to symptom duration: dimensionality of the Vertigo Symptom Scale-short form. Vol. 13, Health and Quality of Life Outcomes. 2015. p. 4.
17.
Lopez-Escamez JA, Carey J, Chung WH, Goebel JA, Magnusson M, Mandalà M, et al. Diagnostic criteria for Menière’s disease. Vol. 25, Journal of Vestibular Research. 2015. p. 1–7.
18.
Mantero V, Abate L, Balgera R, La Mantia L, Salmaggi A. Clinical Application of 2017 McDonald Diagnostic Criteria for Multiple Sclerosis. Vol. 14, Journal of Clinical Neurology. 2018. p. 387.
19.
Labbé D, Teranishi M aki, Hess A, Bloch W, Michel O. Activation of caspase-3 is associated with oxidative stress in the hydropic guinea pig cochlea. Vol. 202, Hearing Research. 2005. p. 21–7.
20.
Capaccio P, Pignataro L, Gaini LM, Sigismund PE, Novembrino C, De Giuseppe R, et al. Unbalanced oxidative status in idiopathic sudden sensorineural hearing loss. Vol. 269, European Archives of Oto-Rhino-Laryngology. 2012. p. 449–53.
21.
Calabrese V, Cornelius C, Maiolino L, Luca M, Chiaramonte R, Toscano MA, et al. Oxidative Stress, Redox Homeostasis and Cellular Stress Response in Ménière’s Disease: Role of Vitagenes. Vol. 35, Neurochemical Research. 2010. p. 2208–17.
22.
Ozer F, Unal OF, Atas A, Tekin O, Sungur A, Ayas K. Evaluation of the effect of dexamethasone in experimentally induced endolymphatic hydrops in guinea pigs. Vol. 29, American Journal of Otolaryngology. 2008. p. 88–93.
23.
Morales-Luckie E, Cornejo-Suarez A, Zaragoza-Contreras MA, Gonzalez-Perez O. Oral Administration of Prednisone to Control Refractory Vertigo in Ménière’s Disease: A Pilot Study. Vol. 26, Otology & Neurotology. 2005. p. 1022–6.
24.
Teranishi M, Uchida Y, Nishio N, Kato K, Otake H, Yoshida T, et al. Polymorphisms in Genes Involved in Oxidative Stress Response in Patients with Sudden Sensorineural Hearing Loss and Ménière’s Disease in a Japanese Population. Vol. 31, DNA and Cell Biology. 2012. p. 1555–62.
25.
Boulassel MR, Tomasi JP, Deggouj N, Gersdorff M. Identification of beta-actin as a candidate autoantigen in autoimmune inner ear disease. Vol. 25, Clinical Otolaryngology and Allied Sciences. 2000. p. 535–41.
26.
Greco A, Gallo A, Fusconi M, Marinelli C, Macri GF, de Vincentiis M. Meniere’s disease might be an autoimmune condition? Vol. 11, Autoimmunity Reviews. 2012. p. 731–8.
27.
Kim SH, Kim JY, Lee HJ, Gi M, Kim BG, Choi JY. Autoimmunity as a Candidate for the Etiopathogenesis of Meniere’s Disease: Detection of Autoimmune Reactions and Diagnostic Biomarker Candidate. Vol. 9, PLoS ONE. p. e111039.
28.
Takumida M, Takeda T, Takeda S, Kakigi A, Nakatani H, Anniko M. Protective effect of edaravone against endolymphatic hydrops. Vol. 127, Acta Oto-Laryngologica. 2007. p. 1124–31.
29.
Takumida M, Anniko M, Ohtani M. Radical scavengers for Ménière’s disease after failure of conventional therapy: a pilot study. Vol. 123, Acta Oto-Laryngologica. 2003. p. 697–703.
Citation
Copyright
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Article metrics
Google scholar:
See link
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
